A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
Yiyun Wang, Yingying Yang, Ruimin Hong, Houli Zhao, Guoqing Wei, Wenjun Wu, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex H. Chang, Yongxian Hu, He Huang
Topics & Concepts
CD22CD19Chimeric antigen receptorMedicineRefractory (planetary science)OncologyInternal medicineAntigenHematologyImmunologyCancer researchImmunotherapyBiologyCancerAstrobiologyCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsVirus-based gene therapy research